Re: Secured $6M Convertable Debenture
|
3
|
Resverlogix Corp.
|
Apr 16, 2024 01:45PM
|
Re: Annual Financial Reporting
|
6
|
Resverlogix Corp.
|
Apr 02, 2024 08:12AM
|
Its tax season and I am playing with numbers…
|
4
|
Resverlogix Corp.
|
Mar 27, 2024 09:06AM
|
Re: What’s the point - short interest doubled lol
|
6
|
Zenith Epigenetics
|
Mar 21, 2024 01:11PM
|
Re: Crazy Question
|
3
|
Resverlogix Corp.
|
Jan 05, 2024 03:06PM
|
Re: Letting them ride ,
|
2
|
Resverlogix Corp.
|
Jan 02, 2024 02:52PM
|
Re: Letting them ride ,
|
4
|
Resverlogix Corp.
|
Jan 02, 2024 02:40PM
|
Re: all through the house
|
6
|
Resverlogix Corp.
|
Dec 27, 2023 01:17PM
|
Re: got this & sent a response/follow up minutes before …
|
6
|
Zenith Epigenetics
|
Dec 12, 2023 12:08PM
|
Re: Rumour has it
|
9
|
Resverlogix Corp.
|
Sep 13, 2023 01:50PM
|
Re: find it interesting that RVXCF.....
|
3
|
Resverlogix Corp.
|
Nov 10, 2022 02:19PM
|
Re: SP 884+ Week Low.
|
3
|
Resverlogix Corp.
|
Oct 13, 2022 01:24PM
|
Don't miss your chance - anyone interested in applying?
|
4
|
Resverlogix Corp.
|
Jul 05, 2022 07:36AM
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 16, 2022 11:32AM
|
Re: Seems to be some interest
|
2
|
Resverlogix Corp.
|
Apr 12, 2022 03:49PM
|
Venting Friday!
|
13
|
Resverlogix Corp.
|
Feb 25, 2022 09:10AM
|
New RVX Video - from Fontier Merchant Capital Group
|
3
|
Resverlogix Corp.
|
Feb 23, 2022 02:59PM
|
Re: News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
5
|
Zenith Epigenetics
|
Feb 22, 2022 09:12AM
|
News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
4
|
Zenith Epigenetics
|
Feb 22, 2022 08:50AM
|
More News Coverage on Global
|
12
|
Resverlogix Corp.
|
Feb 03, 2022 01:37PM
|